NOVEOME

Pharmaceutical preparations consisting primarily of amniotic cells for modulating immune system function, modulating tissue rejection, and repairing damaged tissues; Pharmaceutical preparations consisting primarily of cell growth medium conditioned by amniotic cells for modulating inflammation, repairing damaged tissues, and restoring tissue homeostasis; house mark for pharmaceutical preparations for modulating immune system function, modulating tissue rejection, repairing damaged tissues, modulating inflammation, and restoring tissue homeostasis